In the first round of financing series in support of their neuropsychiatric diagnosis and treatments, the Mindstrong Health managed to raise 14 million dollars. Mindstrong Health is a neurological minded start-up. They have employed an Al-powered platform which is meant to take notes on the interaction patterns via smartphones to monitor brain functions. Mindstrong is intent on avail cognition and mood biomarkers digitally in a continuous manner. This is noted to encompass attention, speed, and executive as well as memory function. ARCH Venture Partners spearheaded this first round of financing, Foresite Capital, Optum Ventures, One Mind Brain Health Impact Fund, as well as Berggruen Holdings.
Dr. Tom Insel, who is the Mindstrong Health President and co-founder, said that the most exciting part of Mindstrong is seeing how individuals are transforming their typing and scrolling mannerisms on smart devices into the meticulous cognitive function,. This cutting edge process is just a benchmark for monitoring and a step to making more impressive ways to improve mental health. The world population faces mental issues, and such problems are not exclusive to one group. He attests that smartphones are a step forward to monitor and could help manage such issues.
Also, the CEO of Foresite Capital, Jim Tananbaum, said that the team that founded Mindstrong Health has incomparable knowledge of how the medical field goes about to treat and care for those ailing from mental complications and disorders. All those worried about helping and bettering the experience of these patients will now have a platform that greatly enhances how such treatments are tackled. The Mindstrong Health CEO, DR. Paul Dagum, added that all the new medicine is now measured objectively, but the mental tracking of patients has been constricted to the clinics. To be able to help the patients effectively, they look to have measures that are currently there for patients with chronic diseases, which is the intention of Mindstrong Health.
Jim Tananbaum, along with Foresite Capital, has been key in aiding the medical industry by investing in worthwhile ventures that are made to improve the treatment of those afflicted by conditions that do not yet have proper/modern means of treatment. They boast of 1.1 billion dollars in assets which they manage. Jim has been in the medical circles for over 20 years and has gone to found his own biopharmaceutical companies as well as healthcare investment practices such as NASDAQ: GENZ, Theravance Inc, and much more. Jim is a Yale graduate holding BSEE and BS degrees, a Harvard M.D and also M.S from MIT.
Follow him on Twitter